[Vena cava filters in complicated venous thromboembolism. Ten years' experiences at Malmo University Hospital].
All 74 patients treated with vena cava filter insertion during 1991-2000 at Malmö University Hospital were reviewed. Thirty-nine patients (53%) died during follow-up. Indications for permanent filter insertion (n = 63, age 25-89 years, 35 men) were contraindication for or side effects of anticoagulant treatment, or pulmonary embolism during anticoagulant treatment. Temporary vena cava filters (n = 11, age 19-85 years, three men) were inserted during surgery or thrombolysis. No complications occurred during temporary filter insertion. During 33 (1-120) months of follow-up of patients with permanent vena cava filters 37 patients (59%) died, thrombosis of the inferior vena cava occurred in 14 patients (22%), and recurrent pulmonary embolism in five patients (8%). Vena cava filter insertion should be considered as an alternative treatment in a selected group of patients with contraindications to or insufficient effect of anticoagulant treatment.
Alhadad
Alaa
A
Kliniken för kärlsjukdomar, Universitetssjukhuset MAS, Malmö.
Bromander
Sara
S
Uher
Petr
P
Ivancev
Krasnodar
K
Mattiasson
Ingrid
I
Gottsäter
Anders
A
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000009:adverse effects; D000075202:Contraindications; D004868:Equipment Failure; D005260:Female; D005500:Follow-Up Studies; D006785:Hospitals, University / Q000592:standards / Q000706:statistics & numerical data; D006801:Humans; D008297:Male; D008875:Middle Aged; D017063:Outcome Assessment, Health Care; D011655:Pulmonary Embolism / Q000150:complications / Q000000981:diagnostic imaging / Q000628:therapy; D011859:Radiography; D013548:Sweden; D013923:Thromboembolism / Q000150:complications / Q000000981:diagnostic imaging / Q000628:therapy*; D016306:Vena Cava Filters / Q000009:adverse effects; D014682:Vena Cava, Inferior / Q000000981:diagnostic imaging; D020246:Venous Thrombosis / Q000150:complications / Q000000981:diagnostic imaging / Q000628:therapy*
D000925:Anticoagulants